Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 3/20 | 0.50 |
| ▸ | PDE4B | Q07343 | 9/20 | 0.46 |
| ▸ | PDE4A | P27815 | 4/20 | 0.46 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.46 |
| ▸ | QDPR | P09417 | 2/20 | 0.43 |
| ▸ | HTR1D | P28221 | 2/20 | 0.40 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.40 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.40 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.40 |
| ▸ | VEGFA | P15692 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20155928 | 0.82 | PDE4A (0.47) | HTR2APDE4BPDE4APDE4CPDE4D | |
| SCHEMBL20073697 | 0.78 | QDPR (0.46) | HTR2APDE4BPDE4APDE4CPDE4D | |
| SCHEMBL11719342 | 0.78 | MEN1 (0.45) | HTR2APDE4BPDE4APDE4CPDE4D | |
| SCHEMBL11487284 | 0.78 | MEN1 (0.51) | HTR2APDE4BPDE4APDE4CPDE4D | |
| SCHEMBL9325871 | 0.78 | PDE4A (0.59) | PDE4BPDE4APDE4CPDE4DQDPR | |
| SCHEMBL27715450 | 0.77 | ALDH1A1 (0.48) | HTR2APDE4BPDE4APDE4CPDE4D | |
| SCHEMBL19695469 | 0.76 | ALDH1A1 (0.40) | — | |
| SCHEMBL9188312 | 0.75 | NR3C1 (0.60) | PDE4BPDE4APDE4CPDE4DQDPR | |
| SCHEMBL11477940 | 0.75 | FFAR4 (0.48) | PDE4BPDE4APDE4CPDE4DQDPR | |
| SCHEMBL20073494 | 0.75 | ALDH1A1 (0.50) | HTR2APDE4BPDE4APDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8148536-B2 | Comestible compositions comprising high potency savory flavorants, and processes for producing them | SENOMYX, INC. (US) | 2012-04-03 | — | — | US | disclosed |
| US-20090280230-A1 | COMESTIBLE COMPOSITIONS COMPRISING HIGH POTENCY SAVORY FLAVORANTS, AND PROCESSES FOR PRODUCING THEM | SENOMYX, INC. | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090280230-A1 | COMESTIBLE COMPOSITIONS COMPRISING HIGH POTENCY SAVORY FLAVORANTS, AND PROCESSES FOR PRODUCING THEM | TAS1R1, TAS1R2, GRM1 | HTR2A 708/4885PDE4B 2563/4885PDE4A 2530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.